Estrella Immunopharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Estrella Immunopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q3 2024.
  • Estrella Immunopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.38M, a 80.5% decline year-over-year.
  • Estrella Immunopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$8.82M, a 18.5% decline year-over-year.
  • Estrella Immunopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$7.31M, a 34.2% increase from 2023.
  • Estrella Immunopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$11.1M, a 1016% decline from 2022.
  • Estrella Immunopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$996K, a 302% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$8.82M -$3.38M -$1.51M -80.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$7.31M -$3.95M -$3.88M -5099% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-27
Q1 2024 -$3.44M -$470K +$2.27M +82.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$5.71M -$1.02M +$1.74M +63% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$7.44M -$1.87M +$1.01M +35.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$8.46M -$76K +$284K +78.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 -$8.74M -$2.74M -$2.6M -1841% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$6.14M -$2.76M -$3.44M -504% Oct 1, 2022 Dec 31, 2022 10-Q 2024-05-15
Q3 2022 -$2.7M -$2.89M -$2.78M -2583% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-15
Q2 2022 $74K -$360K -$356K -10015% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $430K -$141K +$678K +82.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-01
Q4 2021 -$248K $682K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$108K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.56K Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$819K Jan 6, 2021 Mar 31, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.